eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0278883|metastatic melanoma |
| Sentences | 3 |
| PubMedID- 25933140 | We here present the first case, to our knowledge, of diffuse nonnecrotizing granulomatous lymphadenopathy occurring simultaneously with disease progression in a patient with metastatic melanoma after receiving the second dose of ipilimumab. |
| PubMedID- 19816942 | Long term presence of a single predominant tyrosinase-specific t-cell clone associated with disease control in a patient with metastatic melanoma. |
| PubMedID- 22973551 | In a recent case report published in the new england journal of medicine, a patient suffering from metastatic melanoma with disease progression on ipilimumab (ipi, yervoy; bristol-myers squibb), a mab that inhibits ctl-associated antigen 4 (ctla-4), an immunologic checkpoint on t cells, showed a favorable response only after receiving local rt for a metastatic spinal lesion (postow et al., 2012). |
Page: 1